| Intestinal permeability in type 1 diabetes: An updated comprehensive overview MØ Mønsted, ND Falck, K Pedersen, K Buschard, LJ Holm, ... Journal of autoimmunity 122, 102674, 2021 | 54 | 2021 |
| PPARs and the development of type 1 diabetes LJ Holm, MØ Mønsted, M Haupt-Jorgensen, K Buschard PPAR research 2020 (1), 6198628, 2020 | 29 | 2020 |
| Reduced phosphatidylcholine level in the intestinal mucus layer of prediabetic NOD mice MØ Mønsted, M Bilgin, M Kuzma, H Pelantová, K Pedersen, P Tomášová, ... Apmis 131 (6), 237-248, 2023 | 6 | 2023 |
| Failure to replicate the diabetes alleviating effect of a maternal gluten-free diet in non-obese diabetic mice MØ Mønsted, LJ Holm, K Buschard, M Haupt-Jorgensen Plos one 18 (9), e0289258, 2023 | 2 | 2023 |
| Oral administration of the small molecule cathepsin S inhibitor LY3000328 accelerates disease onset and impairs glucose tolerance in non-obese diabetic mice T Fløyel, C Frørup, M Haupt-Jorgensen, LJ Holm, K Pedersen, ... Diabetologia 65 (SUPPL 1), S109-S110, 2022 | | 2022 |
